GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (HKSE:03320) » Definitions » 12-1 Month Momentum %

China Resources Pharmaceutical Group (HKSE:03320) 12-1 Month Momentum % : -35.09% (As of May. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-20), China Resources Pharmaceutical Group's 12-1 Month Momentum % is -35.09%.

The industry rank for China Resources Pharmaceutical Group's 12-1 Month Momentum % or its related term are showing as below:

HKSE:03320's 12-1 Month Momentum % is ranked worse than
77.82% of 1109 companies
in the Drug Manufacturers industry
Industry Median: -9.04 vs HKSE:03320: -35.09

Competitive Comparison of China Resources Pharmaceutical Group's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Pharmaceutical Group's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Pharmaceutical Group's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Pharmaceutical Group's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where China Resources Pharmaceutical Group's 12-1 Month Momentum % falls into.



China Resources Pharmaceutical Group  (HKSE:03320) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Resources Pharmaceutical Group  (HKSE:03320) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


China Resources Pharmaceutical Group 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Pharmaceutical Group (HKSE:03320) Business Description

Traded in Other Exchanges
Address
26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, HKG
CR Pharma, is a vertically integrated conglomerate that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the third largest drug distributor by revenue, with a strong presence in Eastern, Northern, and Southern China. Its drug manufacturing segment primarily consists of four listed subsidiaries, Dong E E Jiao, CR Sanjiu, CR Double Crane, and Jiangzhong Pharmaceutical, which are well-known makers of over-the-counter traditional Chinese medicines (or TCM), health supplements, and prescription drugs. We estimate the company's operating income is approximately 53% distribution, 46% manufacturing, and less than 1% retail pharmacies.

China Resources Pharmaceutical Group (HKSE:03320) Headlines

No Headlines